These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1274 related items for PubMed ID: 29336677
1. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. Al-Mutairi NM, Ahmad S, Mokaddas E. Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677 [Abstract] [Full Text] [Related]
2. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country. Ahmad S, Mokaddas E, Al-Mutairi N, Eldeen HS, Mohammadi S. PLoS One; 2016 Sep; 11(4):e0153563. PubMed ID: 27096759 [Abstract] [Full Text] [Related]
3. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. Al-Mutairi NM, Ahmad S, Mokaddas EM. Eur J Med Res; 2019 Dec 05; 24(1):38. PubMed ID: 31806020 [Abstract] [Full Text] [Related]
4. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S. BMC Infect Dis; 2019 Jan 03; 19(1):3. PubMed ID: 30606116 [Abstract] [Full Text] [Related]
6. Characterization of embB mutations involved in ethambutol resistance in multi-drug resistant Mycobacterium tuberculosis isolates in Zambia. Bwalya P, Solo ES, Chizimu JY, Shrestha D, Mbulo G, Thapa J, Nakajima C, Suzuki Y. Tuberculosis (Edinb); 2022 Mar 03; 133():102184. PubMed ID: 35240539 [Abstract] [Full Text] [Related]
7. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. Park J, Shin SY, Kim K, Park K, Shin S, Ihm C. Ann Lab Med; 2018 Jul 03; 38(4):316-323. PubMed ID: 29611381 [Abstract] [Full Text] [Related]
9. Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China. Zhao LL, Sun Q, Liu HC, Wu XC, Xiao TY, Zhao XQ, Li GL, Jiang Y, Zeng CY, Wan KL. Antimicrob Agents Chemother; 2015 Apr 03; 59(4):2045-50. PubMed ID: 25605360 [Abstract] [Full Text] [Related]
11. Correlation of the phenotypic ethambutol susceptibility of Mycobacterium tuberculosis with embB gene mutations in Korea. Park YK, Ryoo SW, Lee SH, Jnawali HN, Kim CK, Kim HJ, Kim SJ. J Med Microbiol; 2012 Apr 03; 61(Pt 4):529-534. PubMed ID: 22174373 [Abstract] [Full Text] [Related]
14. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. Maningi NE, Malinga LA, Antiabong JF, Lekalakala RM, Mbelle NM. BMC Infect Dis; 2017 Dec 28; 17(1):795. PubMed ID: 29282012 [Abstract] [Full Text] [Related]
15. Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates. Tulyaprawat O, Chaiprasert A, Chongtrakool P, Suwannakarn K, Ngamskulrungroj P. Tuberculosis (Edinb); 2019 Jan 28; 114():42-46. PubMed ID: 30711156 [Abstract] [Full Text] [Related]
17. Discordance in Phenotypic and Genotypic Susceptibility Testing for Streptomycin Due to Nonsynonymous/Nonsense/Deletion Frame-Shift Mutations in Gidb Among Clinical Mycobacterium tuberculosis Isolates in Kuwait. Al-Mutairi NM, Ahmad S, Mokaddas E. Med Princ Pract; 2024 Apr 01; 33(4):321-9. PubMed ID: 38560979 [Abstract] [Full Text] [Related]